Close
Smartlab Europe
Achema middle east

Press Releases

Almac secures new metagenomics and enzyme discovery

The BBRSC Programme combines Chemistry and Biochemical Engineering at UCL with Almac’s Biocatalysis Group. The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically...

Curie-Cancer and Roche strengthen partnership to fast-track the development of new molecules

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and the Roche Institute for Research and Translational Medicine are strengthening their collaborative efforts. In 2009, the Institut Curie and Roche signed an initial...

Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes. ...

Pharma Consulting Group Continues its Growth Through Further Acquisition

As part of their “growth by acquisition” strategy, the pharmaceutical recruitment company; Pharma Consulting Group (PCG) has recently acquired Surrey based CSL Recruitment and Consulting Ltd. The acquisition, which took place on the 15th...

Clearside Biomedical to Present Research on Proprietary Retinal Therapeutics Platform at 2013 ARVO Meeting

Clearside Biomedical Inc. a privately held ophthalmic company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases today announced that research on its proprietary retinal therapeutics platform will be presented at the 2013 Annual Meeting of...

Hitachi Aloka Medical, Ltd. Announces the New F37 Ultrasound System

  Hitachi Aloka Medical Ltd. delivers the message for Woman’s Healthcare “Clearly imaging a woman’s life Good things lie ahead” and announces the release of the new F37 at the upcoming ACOG Annual meeting in New Orleans. ...

Transgene Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV at EASL 2013

Transgene SA a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases announced pre-clinical data obtained with its novel immunotherapeutic TG1050 to treat chronic hepatitis B infection (CHB)....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »